Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1039356-95-0

Post Buying Request

1039356-95-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1039356-95-0 Usage

General Description

3-ForMyliMidazo[1,5-a]pyridine-1-carboxylic acid, also known as FMP-1, is a chemical compound with potential applications in medicinal chemistry and drug development. It is a fused heterocyclic compound that contains a pyridine ring and a carboxylic acid group. FMP-1 has been studied for its potential as an anticancer agent, with research suggesting it may have the ability to inhibit the growth of cancer cells. Additionally, it has shown promise as an anti-inflammatory and antioxidant agent, with potential applications in the treatment of inflammatory and oxidative stress-related diseases. Further research is needed to fully understand the biological activities and potential therapeutic uses of 3-ForMyliMidazo[1,5-a]pyridine-1-carboxylic acid.

Check Digit Verification of cas no

The CAS Registry Mumber 1039356-95-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,3,9,3,5 and 6 respectively; the second part has 2 digits, 9 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1039356-95:
(9*1)+(8*0)+(7*3)+(6*9)+(5*3)+(4*5)+(3*6)+(2*9)+(1*5)=160
160 % 10 = 0
So 1039356-95-0 is a valid CAS Registry Number.

1039356-95-0Downstream Products

1039356-95-0Relevant articles and documents

Imidazopyridine CB2 agonists: Optimization of CB2/CB1 selectivity and implications for in vivo analgesic efficacy

Trotter, B. Wesley,Nanda, Kausik K.,Burgey, Christopher S.,Potteiger, Craig M.,Deng, James Z.,Green, Ahren I.,Hartnett, John C.,Kett, Nathan R.,Wu, Zhicai,Henze, Darrell A.,Penna, Kimberly Della,Desai, Reshma,Leitl, Michael D.,Lemaire, Wei,White, Rebecca B.,Yeh, Suzie,Urban, Mark O.,Kane, Stefanie A.,Hartman, George D.,Bilodeau, Mark T.

, p. 2354 - 2358 (2011/06/17)

A new series of imidazopyridine CB2 agonists is described. Structural optimization improved CB2/CB1 selectivity in this series and conferred physical properties that facilitated high in vivo exposure, both centrally and peripherally. Administration of a h

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1039356-95-0